What I think is next for Standard Chartered’s dividend

Jay Yao writes what he thinks Standard Chartered management might do with the dividend given the recent approval of the Pfizer vaccine

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Like several other leading British banks, Standard Chartered (LSE: STAN) suspended its dividend earlier in the year because of the pandemic. 

British regulators were concerned about the highly uncertain and economically destructive impact of the coronavirus, and asked banks to not pay out dividends. Standard Chartered canceled its planned final fiscal year 2019 dividend of $0.2 per share.

The dividend suspension worsened the already bearish sentiment around STAN and likely sent the stock lower. Recently, however, things have improved. 

In December, Britain and the US both approved a Covid-19 vaccine from Pfizer that’s around 95% effective. Several more vaccine candidates could be approved soon. 

STAN itself has made something of a comeback as hope builds for the beginning of economic normalization next year. Since late October, shares have risen over 37%. 

Given the stock comeback, here’s what I think will happen next for Standard Chartered’s dividend. 

Reasons I believe Standard Chartered will pay a dividend 

I reckon the odds that Standard Chartered resumes its dividend sometime in the next year are very good.

First, British regulators at the Bank of England are more open to bank dividend payments now that a Covid-19 vaccine exists. Britain’s Prudential Regulation Authority (PRA) recently saidWeighing those considerations, and consistent with the PRA’s view that distributions are an important and necessary part of the functioning of the banking system, the PRA judges that an extension of the exceptional and precautionary action taken in March is not necessary”.

Second, STAN’s financials are strong enough to support a dividend, in my view. The bank is strongly capitalised, with a CET1 ratio of 14.4%. It is also profitable. For the third quarter, Standard Chartered reported earnings per share of 13.6 cents. I reckon there is a pretty decent chance the bank’s earnings could also increase.

Growth in emerging and developing markets in Asia could rebound rather quickly. For example, in an October report, the IMF estimated emerging and developing Asia will grow 8% in 2021. This is up from an estimated shrinkage of 1.7% in 2020. Standard Chartered gets a lot of its profits from Asia. 

Management themselves have also said that they may resume shareholder returns next year, which presumably could include dividends. 

Dividend amount?  

In terms of how much Standard Chartered could pay in dividends next year, it’s uncertain. For 2019, STAN reported underlying earnings per share of 75.7 cents. The board originally intended to pay a total ordinary dividend per share of 27 cents. That gives Standard Chartered an intended 2019 payout ratio of 35.67%.

For fiscal year 2021, if STAN earns the estimated $0.61 per share that analysts expect, and management maintains the same payout ratio of 35.67%, the bank would pay around $0.22 per share. 

Given there is still a lot of uncertainty, however, I think Standard Chartered might pay a lower annual dividend, at least for next year. Interest rates are still low, and the manufacturing and distribution of Covid-19 vaccines will be a difficult process. 

No matter what the final dividend amount next year, however, I’d still buy the stock given its low price to book value ratio of 0.44. I reckon the stock could increase if management executes and interest rates normalize. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jay Yao has no position in any of the shares mentioned. The Motley Fool UK has recommended Standard Chartered. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »